|
1
|
He YY, Zhang XC, Yang JJ, et al:
Prognostic significance of genotype and number of metastatic sites
in advanced non-small-cell lung cancer. Clin Lung Cancer.
15:441–447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rajeswaran A, Trojan A, Burnand B and
Giannelli M: Efficacy and side effects of cisplatin- and
carboplatin-based doublet chemotherapeutic regimens versus
non-platinum-based doublet chemotherapeutic regimens as first line
treatment of metastatic non-small cell lung carcinoma: a systematic
review of randomized controlled trials. Lung Cancer. 59:1–11. 2008.
View Article : Google Scholar
|
|
3
|
Chen Y, Zhu J and Zhang W: Antitumor
effect of traditional Chinese herbal medicines against lung cancer.
Anticancer Drugs. 25:983–989. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang S, Wu X, Tan M, et al: Fighting fire
with fire: poisonous Chinese herbal medicine for cancer therapy. J
Ethnopharmacol. 140:33–45. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kupchan SM, Court WA, Dailey RG, Gilmore
CJ and Bryan RF: Triptolide and tripdiolide, novel antileukemic
diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc.
94:7194–7195. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Corson TW and Crews CM: Molecular
understanding and modern application of traditional medicines:
triumphs and trials. Cell. 130:769–774. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Y, Xiao E, Yuan L and Li G: Triptolide
synergistically enhances antitumor activity of oxaliplatin in colon
carcinoma in vitro and in vivo. DNA Cell Biol. 33:418–425. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao H, Yang Z, Wang X, et al: Triptolide
inhibits ovarian cancer cell invasion by repression of matrix
metalloproteinase 7 and 19 and upregulation of E-cadherin. Exp Mol
Med. 44:633–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakazato T, Sagawa M and Kizaki M:
Triptolide induces apoptotic cell death of multiple myeloma cells
via transcriptional repression of Mcl-1. Int J Oncol. 44:1131–1138.
2014.PubMed/NCBI
|
|
10
|
Chen F, Liu Y, Wang S, et al: Triptolide,
a Chinese herbal extract, enhances drug sensitivity of resistant
myeloid leukemia cell lines through downregulation of HIF-1α and
Nrf2. Pharmacogenomics. 14:1305–1317. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu PP, Liu KC, Huang WW, et al: Triptolide
induces apoptosis in human adrenal cancer NCI-H295 cells through a
mitochondrial-dependent pathway. Oncol Rep. 25:551–557. 2011.
|
|
12
|
Mujumdar N, Banerjee S, Chen Z, et al:
Triptolide activates unfolded protein response leading to chronic
ER stress in pancreatic cancer cells. Am J Physiol Gastrointest
Liver Physiol. 306:G1011–G1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Liu R, Yang Y, Huang Y, Li X and
Shen X: Triptolide-induced in vitro and in vivo cytotoxicity in
human breast cancer stem cells and primary breast cancer cells.
Oncol Rep. 31:2181–2186. 2014.PubMed/NCBI
|
|
14
|
Hsiang YH, Hertzberg R, Hecht S and Liu
LF: Camptothecin induces protein-linked DNA breaks via mammalian
DNA topoisomerase I. J Biol Chem. 260:14873–14878. 1985.PubMed/NCBI
|
|
15
|
Zaki NM: Augmented cytotoxicity of
hydroxycamptothecin-loaded nanoparticles in lung and colon cancer
cells by chemosensitizing pharmaceutical excipients. Drug Deliv.
21:265–275. 2014. View Article : Google Scholar
|
|
16
|
Hu W, Zhang C, Fang Y and Lou C:
Anticancer properties of 10-hydroxycamptothecin in a murine
melanoma pulmonary metastasis model in vitro and in vivo. Toxicol
In Vitro. 25:513–520. 2011. View Article : Google Scholar
|
|
17
|
Fu YR, Yi ZJ, Yan YR and Qiu ZY:
Hydroxycamptothecin-induced apoptosis in hepatoma SMMC-7721 cells
and the role of mitochondrial pathway. Mitochondrion. 6:211–217.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kotoh S, Naito S, Yokomizo A, et al:
Increased expression of DNA topoisomerase I gene and collateral
sensitivity to camptothecin in human cisplatin-resistant bladder
cancer cells. Cancer Res. 54:3248–3252. 1994.PubMed/NCBI
|
|
19
|
Liu Y, Chen F, Wang S, et al: Low-dose
triptolide in combination with idarubicin induces apoptosis in AML
leukemic stem-like KG1a cell line by modulation of the intrinsic
and extrinsic factors. Cell Death Dis. 4:e9482013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alsaied OA, Sangwan V, Banerjee S, et al:
Sorafenib and triptolide as combination therapy for hepatocellular
carcinoma. Surgery. 156:270–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang XY, Zhu YQ, Tao WH, Wei B and Lin XL:
Synergistic effect of triptolide combined with 5-fluorouracil on
colon carcinoma. Postgrad Med J. 83:338–343. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pigneux A, Mahon FX, Uhalde M, et al:
Triptolide cooperates with chemotherapy to induce apoptosis in
acute myeloid leukemia cells. Exp Hematol. 36:1648–1659. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Z, Sangwan V, Banerjee S, et al:
Triptolide sensitizes pancreatic cancer cells to TRAIL-induced
activation of the death receptor pathway. Cancer Lett. 348:156–166.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang W, Yang S, Su Y, et al: Enhanced
antitumor effect of combined triptolide and ionizing radiation.
Clin Cancer Res. 13:4891–4899. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang SW, Wang W, Xie XY, Zhu WP and Li FQ:
In vitro synergistic cytotoxic effect of triptolide combined with
hydroxycamptothecin on pancreatic cancer cells. Am J Chin Med.
39:121–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: the combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chou TC: Theoretical basis, experimental
design, and computerized simulation of synergism and antagonism in
drug combination studies. Pharmacol Rev. 58:621–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng G, Sun Y, Fu W, Guo Z and Xu L:
Microcystin-LR induces cytoskeleton system reorganization through
hyperphosphorylation of tau and HSP27 via PP2A inhibition and
subsequent activation of the p38 MAPK signaling pathway in
neuroendocrine (PC12) cells. Toxicology. 290:218–229. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao S, Xiong Z, Mao X, et al: Atmospheric
pressure room temperature plasma jets facilitate oxidative and
nitrative stress and lead to endoplasmic reticulum stress dependent
apoptosis in HepG2 cells. PLoS One. 8:e736652013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han J, Back SH, Hur J, et al:
ER-stress-induced transcriptional regulation increases protein
synthesis leading to cell death. Nat Cell Biol. 15:481–490. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakagawa T, Zhu H, Morishima N, et al:
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and
cytotoxicity by amyloid-beta. Nature. 403:98–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Komatsu M, Furukawa T, Ikeda R, et al:
Involvement of mitogen-activated protein kinase signaling pathways
in microcystin-LR-induced apoptosis after its selective uptake
mediated by OATP1B1 and OATP1B3. Toxicol Sci. 97:407–416. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cowan KJ and Storey KB: Mitogen-activated
protein kinases: new signaling pathways functioning in cellular
responses to environmental stress. J Exp Biol. 206:1107–1115. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Downward J: Mechanisms and consequences of
activation of protein kinase B/Akt. Curr Opin Cell Biol.
10:262–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sontag E: Protein phosphatase 2A: the
Trojan Horse of cellular signaling. Cell Signal. 13:7–16. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen W, Wang Z, Jiang C and Ding Y:
PP2A-mediated anti-cancer therapy. Gastroenterol Res Pract.
2013:6754292013. View Article : Google Scholar
|
|
37
|
Perrotti D and Neviani P: Protein
phosphatase 2A: a target for anticancer therapy. Lancet Oncol.
14:e229–e238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Janssens V and Rebollo A: The role and
therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic
signalling networks in human cancer cells. Curr Mol Med.
12:268–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen J, Martin BL and Brautigan DL:
Regulation of protein serine-threonine phosphatase type-2A by
tyrosine phosphorylation. Science. 257:1261–1264. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY
and Chiang CW: Regulation of phosphorylation of Thr-308 of Akt,
cell proliferation, and survival by the B55alpha regulatory subunit
targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol
Chem. 283:1882–1892. 2008. View Article : Google Scholar
|
|
41
|
Lee ER, Kim JH, Choi HY, Jeon K and Cho
SG: Cytoprotective effect of eriodictyol in UV-irradiated
keratinocytes via phosphatase-dependent modulation of both the p38
MAPK and Akt signaling pathways. Cell Physiol Biochem. 27:513–524.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen L, Liu L, Yin J, Luo Y and Huang S:
Hydrogen peroxide-induced neuronal apoptosis is associated with
inhibition of protein phosphatase 2A and 5, leading to activation
of MAPK pathway. Int J Biochem Cell Biol. 41:1284–1295. 2009.
View Article : Google Scholar
|
|
43
|
Li XJ, Jiang ZZ and Zhang LY: Triptolide
progress on research in pharmacodynamics and toxicology. J
Ethnopharmacol. 155:67–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tan W, Lu J, Huang M, et al: Anti-cancer
natural products isolated from chinese medicinal herbs. Chin Med.
6:272011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen YW, Huang CF, Yang CY, Yen CC, Tsai
KS and Liu SH: Inorganic mercury causes pancreatic beta-cell death
via the oxidative stress-induced apoptotic and necrotic pathways.
Toxicol Appl Pharmacol. 243:323–331. 2010. View Article : Google Scholar
|
|
47
|
Carter BZ, Mak DH, Schober WD, et al:
Triptolide induces caspase-dependent cell death mediated via the
mitochondrial pathway in leukemic cells. Blood. 108:630–637. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang Q, Du H, Geng G, et al: Matrine
inhibits proliferation and induces apoptosis via BID-mediated
mitochondrial pathway in esophageal cancer cells. Mol Biol Rep.
41:3009–3020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li Y, Zhang S, Geng JX and Hu XY: Curcumin
inhibits human non-small cell lung cancer A549 cell proliferation
through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J
Cancer Prev. 14:4599–4602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qin R, Shen H, Cao Y, et al: Tetrandrine
induces mitochondria-mediated apoptosis in human gastric cancer
BGC-823 cells. PLoS One. 8:e764862013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Giorgi C, De Stefani D, Bononi A, Rizzuto
R and Pinton P: Structural and functional link between the
mitochondrial network and the endoplasmic reticulum. Int J Biochem
Cell Biol. 41:1817–1827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Deniaud A, Sharaf el dein O, Maillier E,
et al: Endoplasmic reticulum stress induces calcium-dependent
permeability transition, mitochondrial outer membrane
permeabilization and apoptosis. Oncogene. 27:285–299. 2008.
View Article : Google Scholar
|
|
54
|
Pinton P, Giorgi C, Siviero R, Zecchini E
and Rizzuto R: Calcium and apoptosis: ER-mitochondria
Ca2+ transfer in the control of apoptosis. Oncogene.
27:6407–6418. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shao H, Ma J, Guo T and Hu R: Triptolide
induces apoptosis of breast cancer cells via a mechanism associated
with the Wnt/β-catenin signaling pathway. Exp Ther Med. 8:505–508.
2014.PubMed/NCBI
|
|
56
|
Whitmarsh AJ and Davis RJ: Transcription
factor AP-1 regulation by mitogen-activated protein kinase signal
transduction pathways. J Mol Med (Berl). 74:589–607. 1996.
View Article : Google Scholar
|
|
57
|
Xia Z, Dickens M, Raingeaud J, Davis RJ
and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases
on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lee ER, Kang YJ, Kim JH, Lee HT and Cho
SG: Modulation of apoptosis in HaCaT keratinocytes via differential
regulation of ERK signaling pathway by flavonoids. J Biol Chem.
280:31498–31507. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Leung HW, Hour MJ, Chang WT, et al:
P38-associated pathway involvement in apoptosis induced by
photodynamic therapy with Lonicera japonica in human lung squamous
carcinoma CH27 cells. Food Chem Toxicol. 46:3389–3400. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Turowski P, Favre B, Campbell KS, Lamb NJ
and Hemmings BA: Modulation of the enzymatic properties of protein
phosphatase 2A catalytic subunit by the recombinant 65-kDa
regulatory subunit PR65alpha. Eur J Biochem. 248:200–208. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Muslin AJ: MAPK signalling in
cardiovascular health and disease: molecular mechanisms and
therapeutic targets. Clin Sci (Lond). 115:203–218. 2008. View Article : Google Scholar
|
